Arno Therapeutics, Inc.
ARNI · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $67 | $7,948 | $26,774 | $10,943 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $261 | $258 | $86 | $204 |
| Total Curr. Assets | $328 | $8,206 | $26,860 | $11,147 |
| Property Plant & Equip (Net) | $23 | $31 | $12 | $25 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $10 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $10 | $10 | $1,710 |
| Total NC Assets | $34 | $41 | $22 | $1,745 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $361 | $8,248 | $26,883 | $12,892 |
| Liabilities | – | – | – | – |
| Payables | $1,010 | $742 | $2,942 | $1,553 |
| Short-Term Debt | $2,094 | $3 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,127 | $1,411 | $959 | $1,693 |
| Total Curr. Liab. | $4,231 | $2,157 | $3,901 | $3,246 |
| LT Debt | $4 | $8 | $0 | $491 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,751 | $6,672 | $35,865 | $21,420 |
| Total NC Liab. | $4,755 | $6,679 | $35,865 | $21,911 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $11 | $0 | $0 |
| Total Liabilities | $8,985 | $8,837 | $39,766 | $25,158 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $3,548 | $362 | $0 |
| Common Stock | $5 | $5 | $5 | $4 |
| Retained Earnings | -$93,295 | -$81,787 | -$89,558 | -$49,901 |
| AOCI | $0 | $0 | -$362 | $0 |
| Other Equity | $84,665 | $81,193 | $77,031 | $37,631 |
| Total Equity | -$8,624 | -$589 | -$12,883 | -$12,266 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $361 | $8,248 | $26,883 | $12,892 |
| Net Debt | $2,031 | -$7,937 | -$26,774 | -$10,452 |